Subacute liver failure caused by immunotherapy in a patient with gastric cancer was improved after multimodal treatment with artificial liver combined with liver-protective drugs: a case report
The emergence of the anti-tumor immunotherapy era has led to the widespread adoption of immune checkpoint inhibitors (ICIs) in clinical practice. While ICIs exhibit substantial anti-tumor efficacy across a broad range of malignancies, they may also ind…